Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Congleton Jon
Over the trailing 90 days, Congleton Jon (Director at Mineralys Therapeutics, Inc.) sold $2.3M of stock across 2 companies, per 5 SEC Form 4 transactions.
- Role
- Director
- Window
- Trailing 90 days · 5 transactions · CIK 1644975
- Net activity
- −$2.3M ($0 bought · $2.3M sold)
By Company (Trailing 90 Days)
Transactions (5)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-07-13 | MLYS | Sell | 10.7K | $291K | Open market or private sale |
| 2026-07-05 | IMUX | Buy | 25.4K | $0 | Grant, award or other acquisition |
| 2026-06-30 | MLYS | Sell | 58.0K | $1.5M | Open market or private sale |
| 2026-06-30 | MLYS | Sell | 17.0K | $456K | Open market or private sale |
| 2026-06-29 | IMUX | Buy | 50.7K | $0 | Grant, award or other acquisition |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Congleton's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.